Sinopharm Tech Holdings Income Statement

Financials in millions HKD. Fiscal year is July - June.

Millions HKD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	61.25	41.28	42.84	40.99	77.81
Revenue Growth (YoY)	48.39%	-3.65%	4.52%	-47.33%	-53.11%
Cost of Revenue	47.02	36.26	37.37	39.22	58.59
Gross Profit	14.23	5.02	5.47	1.77	19.23
Selling, General & Admin	12.93	14.18	21.47	42.43	62.22
Operating Expenses	21.07	15.42	20.59	76.39	75.08
Operating Income	-6.84	-10.4	-15.12	-74.62	-55.85
Interest Expense	-5.85	-23.93	-8.57	-16.41	-14.55
Interest & Investment Income	0	0.08	0	0	0
Earnings From Equity Investments	-	-	0.19	-0.15	3.59
Other Non Operating Income (Expenses)	-0.29	0.26	31.19	3.84	4.6
EBT Excluding Unusual Items	-12.97	-33.99	7.68	-87.34	-62.21
Impairment of Goodwill	-	-	-	-12.31	-33.83
Gain (Loss) on Sale of Investments	1.1	-2.73	-18.53	-21.89	-
Gain (Loss) on Sale of Assets	6.93	16.56	-	8.69	0.37
Asset Writedown	-	-	-	-8.13	-4.6
Other Unusual Items	3.86	-0.16	-	26.82	-10.8
Pretax Income	-1.08	-20.33	-10.85	-94.16	-111.06
Income Tax Expense	0.29	0.08	-1.31	-0.39	-0.56
Earnings From Continuing Operations	-1.37	-20.42	-9.54	-93.77	-110.51
Earnings From Discontinued Operations	-	0.39	-0.56	-	-
Net Income to Company	-1.37	-20.03	-10.1	-93.77	-110.51
Minority Interest in Earnings	0.5	0.33	-0.54	5.77	4.17
Net Income	-0.87	-19.7	-10.64	-88	-106.34
Net Income to Common	-0.87	-19.7	-10.64	-88	-106.34
Shares Outstanding (Basic)	465	184	183	180	172
Shares Outstanding (Diluted)	465	184	183	180	172
Shares Change (YoY)	153.03%	0.45%	1.66%	4.59%	4.39%
EPS (Basic)	-0.00	-0.11	-0.06	-0.49	-0.62
EPS (Diluted)	-0.00	-0.11	-0.06	-0.49	-0.62
Free Cash Flow	-5.7	-12.58	4.73	-36.89	-16.33
Free Cash Flow Per Share	-0.01	-0.07	0.03	-0.20	-0.10
Gross Margin	23.23%	12.16%	12.77%	4.32%	24.71%
Operating Margin	-11.16%	-25.20%	-35.29%	-182.06%	-71.78%
Profit Margin	-1.42%	-47.72%	-24.83%	-214.71%	-136.66%
Free Cash Flow Margin	-9.30%	-30.48%	11.05%	-90.00%	-20.98%
EBITDA	-6.12	-9.76	-13.91	-73.3	-50.54
EBITDA Margin	-9.99%	-23.66%	-32.48%	-178.84%	-64.95%
D&A For EBITDA	0.72	0.64	1.21	1.32	5.31
EBIT	-6.84	-10.4	-15.12	-74.62	-55.85
EBIT Margin	-11.16%	-25.20%	-35.29%	-182.06%	-71.78%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.